Pulmonary arterial hypertension (PAH) is an increasingly understood disease, with the genetics and pathophysiology mapped out to the extent that new therapies are emerging.1 The epidemiology, however, ...

((SL Advertiser)) New treatment option for those with chronic obstructive pulmonary disease or COPD. To learn more, go to ...

The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down ...

Dr. Kurdi received his Medical Degree with honors from The Faculty of Medicine of Damascus University. Dr. Kurdi also completed his residency at St. Joseph Mercy Hospital, Oakland, MI, a fellowship in ...

Its growth is attributed to the introduction of new treatments. The chronic obstructive pulmonary disease (COPD) market is ...

This is where lifestyle medicine enters the scene. This is a relatively new genera of medicine, which focuses primarily on ...

Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

Researchers from the Center for Regenerative Medicine (CReM) at Boston University and (BMC) have announced a new collaboration with the global biopharma company GSK to advance innovative research ...

Patients with COPD and type 2 diabetes using SGLT2i were much less likely to have ER visits and hospitalizations related to COPD exacerbations.

Experts explored the latest trends, approvals, and pipeline developments in cell and gene therapies, rare disease, immunology ...

In the United States, more than 10 million people above the age of 40 live with chronic obstructive pulmonary disease (COPD), a chronic lung disease that limits air flow and causes ...

In patients with COPD both with or without heart failure, AF episodes rise around the time patients are hospitalized for ...